Application of blood GM test combined with bronchoscope alveolar lavage fluid in the diagnosis of pulmonary aspergillosis
ZHOU Yongjun1 MENG Yaqi2 BAO Yiqin3 WANG Zhu4
1.Department of Respiratory Medicine, Jianhu Hospital Affiliated to Nantong University, Jiangsu Province, Yancheng 224700, China;
2.Department of Respiratory and Critical Care Medicine, Jiangsu Provincial People’s Hospital, Jiangsu Province, Nanjing 210029, China;
3.Department of Respiratory and Critical Care Medicine, Wuhu Second People’s Hospital, Anhui Province, Wuhu 241000, China;
4.Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, Jiangsu Province, Xuzhou 221000, China
Abstract：Objective To investigate the value of serum and alveolar lavage fluid galactomannan (GM) test in the diagnosis of pulmonary aspergillosis. Methods From June 2015 to June 2019, 90 patients with suspected pulmonary aspergillosis treated in Jianhu Hospital Affiliated to Nantong University were selected as research subjects. Patients received a combination of serum and alveolar lavage fluid GM therapy. GM values of serum and alveolar lavage fluid of different patients were compared according to clinical diagnosis, and the ROC curve was used to analyze the diagnostic value of GM values of serum and alveolar lavage fluid in diagnosing pulmonary aspergillosis. Results Among 90 patients suspected of pulmonary aspergillosis, pulmonary aspergillosis was confirmed in 39 cases, pulmonary aspergillosis was suspected in 21 cases and non-pulmonary aspergillosis in 30 cases. The GM values of serum and alveolar lavage fluid in confirmed and suspected pulmonary aspergillus patients were higher than those in non-aspergillus patients (P < 0.05). The area under curve of ROC of GM value of serum and alveolar lavage fluid in diagnosing pulmonary aspergillosis were 0.794 and 0.870 respectively, the cut-off values were 0.43 and 0.88 respectively, the sensitivity were 74.00% and 82.00% respectively, the specificity were 75.00% and 100.00% respectively. By parallel test, the sensitivity and specificity of serum combined with alveolar lavage fluid GM value for diagnosis of aspergillus disease were 88.00% and 85.00%; by tandem test, the sensitivity and specificity of serum combined with alveolar lavage fluid GM for diagnosis of aspergillosis were 70.00% and 100.00%. Conclusion The GM test of serum and alveolar lavage fluid has a good application value in the diagnosis of pulmonary aspergillosis and is worth clinical use.
周永军1 孟亚奇2 鲍姨琴3 王柱4. 血GM试验联合气管镜肺泡灌洗液在肺曲霉病诊断中的应用[J]. 中国医药导报, 2021, 18(11): 125-128.
ZHOU Yongjun1 MENG Yaqi2 BAO Yiqin3 WANG Zhu4. Application of blood GM test combined with bronchoscope alveolar lavage fluid in the diagnosis of pulmonary aspergillosis. 中国医药导报, 2021, 18(11): 125-128.
[1] 邓劲，吴思颖，康梅.血清及肺泡灌洗液半乳甘露聚糖检测对非粒细胞缺乏患者侵袭性曲霉菌感染的诊断价值[J].检验医学与临床，2017，14（12）：1762-1764.
[2] 邓劲，吴思颖，刘雅，等.支气管肺泡灌洗液半乳甘露聚糖试验对侵袭性肺曲霉菌病的诊断价值[J].四川大学学报：医学版，2018，49（1）：124-128.
[3] 龚正，龚萍，金柱，等.侵袭性肺曲霉菌患者CT影像学与肺泡灌洗液半乳甘露聚糖检测阳性之间关系[J].中国临床医学影像杂志，2017，28（1）：27-29.
[4] Gupta A，Capoor MR，Shende T，et al. Comparative evaluation of galactomannan test with bronchoalveolar lavage and serum for the diagnosis of invasive aspergillosis in patients with hematological malignancies [J]. J Lab Physicians，2017，9（4）：234-238.
[5] 周新.解读侵袭性肺部真菌感染的诊断标准与治疗原则（草案）[J].中华内科杂志，2006，26（21）：1752-1753.
[6] Sabour S. Serum galactomannan antigen test combined with chest computed tomography for invasive pulmonary aspergillosis in pediatric patients after hematopoietic stem cell transplantation; Methodological issues on early diagnostic value [J]. Clin Transplant，2020，34（3）：13789.
[7] 张成飞，翟甜甜，张岩钊，等.血清半乳甘露聚糖试验对非粒细胞缺乏患者侵袭性肺曲霉病的诊断价值评估及影响因素分析[J].中华医院感染学杂志，2018，28（9）：12-15，23.
[8] 李勇，黄慧琴，叶向丽，等.支气管肺泡灌洗液半乳甘露聚糖检测在慢性阻塞性肺病合并侵袭性肺曲霉病诊断中的研究[J].福建医科大学学报，2018，52（6）：385-388.
[9] Kaur R，Mehra B，Dhakad MS，et al. Pulmonary aspergillosis as opportunistic mycoses in a cohort of human immunodeficiency virus-infected patients：Report from a tertiary care hospital in North India [J]. Int J Health Sci，2017，11（2）：45-50.
[10] Tr?覿ger J，Melichar VO，Meyer R，et al. Serum （1→3）-β-D-glucan and galactomannan levels in patients with cystic fibrosis：a retrospective cohort study [J]. BMC Pulm Med，2018，18（1）：52.
[11] 唐安珏，宋卫东，徐平.支气管肺泡灌洗液对免疫功能正常肺曲霉病患者的早期诊断价值[J].中国内镜杂志，2017，23（11）：24-29.
[12] 何骞，沈思梅，周威，等.血清半乳甘露聚糖检测在慢性阻塞性肺疾病并发侵袭性肺曲霉病中的诊断价值[J].医学研究生学报，2017，30（4）：380-383.
[13] Zhou W，Li H，Zhang Y，et al. Diagnostic Value of the Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Non-neutropenic Invasive Pulmonary Aspergillosis [J]. J Clin Microbiol，2017，55（7）：2153-2161.
[14] Kim R，Koh Y，Shin DY，et al. The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis：a retrospective study [J]. Blood Res，2017，52（4）：300-306.
[15] Min Z，Veer M，Rali P，et al. Early-onset de novo invasive pulmonary aspergillosis in an orthotopic heart transplant recipient [J]. Lung India，2017，34（4）：376-379.
[16] Bozbas SS. Culture-Positive Pulmonary Aspergillosis Infection：Clinical and Laboratory Features of Solid-Organ Transplant Recipients [J]. Exp Clin Transplant，2017，15（Suppl 1）：214-218.
[17] Vehreschild JJ，Heussel CP，Groll AH，et al. Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis [J]. Eur Radiol，2017，27（8）：3275-3282.
[18] Pal RS，Spalgais S，Murar AK，et al. Invasive Aspergillus Pseudomembranous and Obstructive Tracheo-bronchitis in an Immuno-competent Patient [J]. J Assoc Physicians India，2017，65（11）：92-93.
[19] Wilson DR, Anne-Marie C, Fady G，et al. Comparing Diagnostic-Driven Approaches to Empiric Therapy in the Treatment of Invasive Aspergillosis in Patients with Hematologic Malignancy [J]. Open Forum Infect Dis，2017（suppl_1）：S81-S82.
[20] Marchesi F，Spadea A，Pimpinelli F，et al. The predictive value of Aaspergillus PCR testing on bronchoalveolar lavage fluid for early diagnosis of invasive pulmonary aspergillosis in hematologic patients [J]. Leuk Lymphoma，2017，58（12）：2943-2946.
[21] Kishore M，Kaushal M，Deepak D，et al. Cytopathological examination of bronchoalveolar lavage fluid in diagnosis of pulmonary alveolar proteinosis [J]. J Lab Physicians，2018，10（1）：109-112.
[22] 温林芳，刘双，李梅，等.变应性支气管肺曲霉病的治疗进展[J].中华内科杂志，2019，58（2）：150-153.
[23] 郭斐，方秋红.伊曲康唑与泼尼松单药治疗急性期变应性支气管肺曲霉病合并支气管哮喘的疗效比较：一项随机对照研究[J].中华结核和呼吸杂志，2018，41（8）：594.
[24] 张玉林，画伟，金荣华.国内传染病临床教学现状与策略思考[J].中国医药导报，2018，477（19）：52-54.
[25] Deng J ，Wu SY，Liuy Y，et al. Galactomannan Tests of Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis [J]. Sichuan Da Xue Xue Bao Yi Xue Ban，2018，49（1）：124-128.
[26] 许树雄，李妙恩，吴卫锋.支气管肺泡灌洗液半乳甘露聚糖检测在侵袭性肺曲霉病患者诊断中的价值[J].中国医药科学，2019，9（1）：183-186.
京公网安备 11010502046598号